Completed Spinoffs

Filter by: Upcoming | Completed

  Spinoff Name Spinoff Symbol Announced Date Spinoff Date First Day Closing Spinoff Last Price Spinoff Performance Spinoff Current Volume Parent Name Parent Symbol Parent First Day Closing Parent Last Price Parent Performace Parent Current Volume Type
Cryptyde TYDE 11/08/2021 06/29/2022 6.30 6.30 0.00% Vinco Ventures, Inc. BBIG 1.97 1.9700 0.00% 17,298,725 Spinoff
Vinco Ventures, Inc., spinoff details:

Vinco Ventures, Inc. (BBIG) announced the filing of a Form 10 registration statement with the United States Securities and Exchange Commission (“SEC”) in connection with the planned spin-off of its subsidiary Cryptyde, Inc. The spin-off would make Cryptyde a stand-alone, publicly traded Nasdaq listed company under the ticker symbol TYDE.

November 08, 2021: Form 10-12B

Update(s):

November 22, 2021: The Company’s subsidiary, Cryptyde, Inc., filed its preliminary Form 10 registration statement with the SEC in connection with the planned spin-off of Cryptyde, which currently owns, directly or indirectly, 100% of EVNT Platform, LLC, CW Machines, LLC and Ferguson Containers, Inc. The distribution date is expected to occur in early 2022.

January 27, 2022: Cryptyde currently a wholly owned subsidiary of Vinco Ventures, Inc (BBIG), which is expected to trade, if approved by Nasdaq, under the symbol TYDE, announced it has entered into definitive agreements for a debt and common equity raise of $42 million.

May 5, 2022: Vinco Ventures, Inc. (BBIG), announced that May 18, 2022 has been set as the record date for the dividend of shares of common stock of Cryptyde, Inc. to be distributed to Vinco stockholders in order to effect the separation of Vinco and Cryptyde into two independent, publicly traded companies.

The share dividend is expected to be distributed to Vinco stockholders on or about May 27, 2022. 

May 25, 2022: Vinco Ventures, Inc. (BBIG), announced that, due to contractual and regulatory conditions, the Company’s Board of Directors has decided to delay the distribution date for the previously announced spin-off of Cryptyde, Inc.

June 23, 2022: Vinco Ventures, Inc. (BBIG), announced that the Company’s Board of Directors has set June 29, 2022 as the distribution date for the dividend of shares of its common stock of Cryptyde, Inc. to be distributed, subject to certain conditions, to Vinco stockholders in order to effect the previously disclosed separation of Vinco and Cryptyde into two independent, publicly traded companies. 

On the Distribution Date, Vinco stockholders entitled to receive the Distribution will receive one share of Cryptyde common stock for every ten shares of Vinco common stock held.

Phoenix Motor Inc. PEV 01/27/2021 06/08/2022 4.06 4.66 14.78% 236,825 SPI Energy Co., Ltd. SPI 2.30 1.71 -25.65% 192,929 Carve Out
SPI Energy Co., Ltd., spinoff details:

January 27, 2021: SPI Energy Co., Ltd., (SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors, today announced its Board of Directors approved the Company's plan to spin off Phoenix Motorcars, a wholly owned subsidiary of the Company's EdisonFuture subsidiary, through an initial public offering.

June 24, 2021: SPI Energy Co., Ltd. (SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors, announced the appointment of Janet Jie Chen as its new Chief Financial Officer.

June 7, 2022:

The Shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on June 8, 2022, under the ticker symbol “PEV.”

Phoenix Motor Inc. (PEV), announced the pricing of its initial public offering of 2,100,000 shares of common stock at a public offering price of $7.50 per Share, for total gross proceeds of $15,750,000

The Shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on June 8, 2022, under the ticker symbol “PEV.”

 

EUROAPI EAPI.PA 02/24/2020 05/06/2022 13.51 15.918 17.82% 531,251 Sanofi SNY 51.13 52.67 3.01% 1,773,589 Carve Out
Sanofi, spinoff details:

February 24, 2020: Sanofi (SNY) plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), which are the essential molecules responsible for the beneficial effects used in the composition of any drug. The project consists of creating a standalone company which would combine Sanofi’s API commercial and development activities with six of its European API production sites : Brindisi (Italy), Frankfurt Chemistry (Germany), Haverhill (UK), St Aubin les Elbeuf (France), Újpest (Hungary) and Vertolaye (France).

April 1, 2022: Investor Presentation

Update(s):

January 12, 2021: Sanofi chooses EUROAPI as the name for the future leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients (API).

April 1, 2022: EUROAPI first day of trading expected to occur on May 6, 2022 subject to the approval of the Distribution by the Ordinary and Extraordinary Shareholders’ Meeting to be held on May 3, 2022

May 6, 2022: EUROAPI (EAPI), a leading player in the API market, announces the success of its listing on the regulated market of Euronext Paris and its first day of trading

Bausch + Lomb Eye Health Business BLCO 08/06/2020 05/06/2022 20.00 15.28 -23.60% 330,858 Bausch Health Companies Inc. BHC 16.04 8.51 -46.95% 4,625,876 Carve Out
Bausch Health Companies Inc., spinoff details:

August 8, 2020: Bausch Health Companies (BHC) announced that it intends to spin off its leading eye health business into an independent publicly traded entity (“Bausch + Lomb - NewCo”) from the remainder of Bausch Health (“BHC”). The spinoff will establish two separate companies that include: •A fully integrated, pure play eye-health company built on the iconic Bausch + Lomb brand and long history of innovation; and •A diversified pharmaceutical company with leading positions in gastroenterology, aesthetics/dermatology, neurology and international pharmaceuticals.

Investor presentation

Update(s):

May 04, 2021: Bausch Health Companies Inc. (BHC) is preparing to spin off its eyecare business this fall while also considering suitable alternatives including a sale of the business, the company's CEO said. Spinoff details

August 03, 2021: Bausch Health (BHC) Announces Plans To Pursue An Initial Public Offering Of Solta Medical. Transaction Will Enable Bausch Health to Continue to Execute on its Previously Announced Spinoff of its Bausch + Lomb Eye Health Business.

November 02, 2021: Bausch Health Companies Inc. (BHC) announced that they expect to launch the proposed IPO of Solta Medical business in December 2021 or January 2022, and following that,  launch the Bausch + Lomb IPO approximately 30 days later.

January 13, 2022: Bausch Health Companies Inc. (BHC) announced that, in connection with its previously announced intention to separate its eye health business, its wholly owned subsidiary, Bausch + Lomb Corporation (BLCO), has publicly filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC").

January 18, 2022: Bausch Health (BHC) announces it is seeking to refinance its existing Credit Agreement and Conditional Redemption Of Existing Notes- These steps will enable Bausch + Lomb IPO (BLCO) and facilitate full separation.

May 10, 2022: Bausch + Lomb Corporation (BLCO) and Bausch Health Companies Inc. (BHC) announced the closing of the initial public offering ("IPO") of Bausch + Lomb. A wholly owned subsidiary of Bausch Health sold 35,000,000 common shares at a public offering price of $18.00 per share for aggregate gross proceeds of $630 million, before deducting underwriting commissions and estimated offering expenses. 

The common shares began trading on the New York Stock Exchange and the Toronto Stock Exchange on May 6, 2022, in each case under the ticker symbol "BLCO." Bausch Health, together with its subsidiaries, now holds approximately 90.0% of the common shares of Bausch + Lomb (before giving effect to the over-allotment option).

Warner Bros. Discovery WBD 05/17/2021 04/08/2022 24.78 13.17 -46.85% 21,300,735 AT&T Inc. T 19.35 20.95 8.27% 26,232,775 Reverse Morris Trust
AT&T Inc., spinoff details:

May 17, 2021: AT&T Inc. (T) and Discovery, Inc. (DISCA, DISCB, DISCK) announced a definitive agreement to combine WarnerMedia’s premium entertainment, sports and news assets with Discovery’s leading nonfiction and international entertainment and sports businesses to create a premier, standalone global entertainment company.

Investor Presentation

Update(s):

June 1, 2021: Discovery, Inc. (DISCADISCBDISCK)  announced the new name of the proposed standalone global entertainment company that will emerge from the combination of WarnerMedia and Discovery assets: "Warner Bros. Discovery." 

June 23, 2021: EA Will Acquire Playdemic for $1.4 Billion in Cash.The remaining Warner Bros. Games portfolio is included in the recently announced WarnerMedia-Discovery transaction and will become part of the combined media and entertainment company after the expected close of that transaction. 

August 10, 2021: The company recently completed its DIRECTV transaction with TPG Capital and is moving forward with its plans to spin or split off WarnerMedia and combine it with Discovery to form a new entertainment company, Warner Bros. Discovery.

September 14, 2021: AT&T (T) continues to anticipate that its pending WarnerMedia-Discovery transaction will close by mid-2022

November 17, 2021: With regard to its pending WarnerMedia transaction with Discovery, the company continues to expect the transaction to close by mid-2022.

While dividend decisions are made at the discretion of the AT&T board of directors, Desroches said that after the transaction closes, AT&T expects an annual dividend payout ratio of 40% to 43% on anticipated free cash flows of $20 billion plus, equating to $8 billion to $9 billion in dividends annually.

December 6, 2021: Regarding the pending WarnerMedia-Discovery transaction, Stankey said the regulatory review process is proceeding as expected. Stankey reiterated expectations of leverage levels of 2.6x at the close of the deal and 2.5x by yearend 2023. 

February 1, 2022: AT&T Inc (T) said it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc (DISCA) and also cut its dividend by nearly half.

AT&T shareholders will own 71% of the new Warner Bros. Discovery company and will receive a 0.24 shares of Warner Bros. Discovery for each AT&T share they own. AT&T will have 7.2 billion diluted shares outstanding after the transaction closes.

February 1, 2022: The transaction, which will spin off 100% of AT&T’s interest in WarnerMedia to AT&T’s existing shareholders in a pro rata distribution, followed by the merger of WarnerMedia with Discovery, is expected to close in the second quarter of 2022.

On the closing date of the transaction, each AT&T shareholder will receive, on a tax-free basis, an estimated 0.24 shares of the new WBD common stock for each share of AT&T common stock held as of the record date for the pro rata distribution.

March 11, 2022: Discovery Inc (DISCAshareholders voted to approve the media company's $43 billion merger with WarnerMedia, moving the deal one step closer to completion.

March 25, 2022:

 AT&T Inc.* (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022. 
 
 On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

 AT&T Inc. (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022.   On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

April 8, 2022: Discovery, Inc. and AT&T Inc.* (Tannounced that they have closed their transaction to combine the WarnerMedia business with Discovery. The combination creates a premier standalone global media and entertainment company, Warner Bros. Discovery, Inc., which will begin trading on the Nasdaq with the start of trading on April 11, under the new ticker symbol “WBD.”

ESAB Corporation ESAB 03/04/2021 04/05/2022 45.05 43.08 -4.37% 259,349 Enovis Corporation (Previously Colfax Corporation) ENOV 70.45 55.67 -20.98% 284,499 Splitoff
Enovis Corporation (Previously Colfax Corporation), spinoff details:

March 4, 2021: Colfax Corporation (CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.

Investor Presentation

Update(s):

November 04, 2021: The Company is making meaningful progress on its expected tax-free spin-off of its ESAB business to Colfax shareholders in the form of a dividend in the first quarter of 2022. Colfax Corporation (CFX) announced that it will transition to its new name, Enovis, at the time of the separation.

February 22, 2022: Colfax (CFXintends to distribute 90% of the outstanding shares in ESAB to Colfax shareholders on a pro rata basis in a distribution intended to be tax-free to Colfax. The Company plans to divest its 10% retained shares in ESAB within 12 months after the spin-off in a tax-efficient exchange for its outstanding debt.

March 11, 2022: Colfax Corporation (CFX), announced the future composition of the Board of Directors of the Company, which will be renamed Enovis Corporation upon the consummation of the Company’s previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corporation.

March 14, 2022: Colfax (CFX) Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation

Upon completion of the distribution, Colfax will effect the Reverse Stock Split and change its name to Enovis Corporation (“Enovis”). Following the distribution, Enovis will trade on the NYSE under the symbol “ENOV.”

March 28, 2022: Colfax (CFX) Announces Board of Directors for Post-Spinoff ESAB. Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directors of ESAB. 

April 5, 2022:

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced  the completion of its previously announced separationof its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 
Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced the completion of its previously announced separation of its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 

Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

  Spinoff Name Announced Date Parent Symbol
Cryptyde 11/08/2021 BBIG
Vinco Ventures, Inc., spinoff details:

Vinco Ventures, Inc. (BBIG) announced the filing of a Form 10 registration statement with the United States Securities and Exchange Commission (“SEC”) in connection with the planned spin-off of its subsidiary Cryptyde, Inc. The spin-off would make Cryptyde a stand-alone, publicly traded Nasdaq listed company under the ticker symbol TYDE.

November 08, 2021: Form 10-12B

Update(s):

November 22, 2021: The Company’s subsidiary, Cryptyde, Inc., filed its preliminary Form 10 registration statement with the SEC in connection with the planned spin-off of Cryptyde, which currently owns, directly or indirectly, 100% of EVNT Platform, LLC, CW Machines, LLC and Ferguson Containers, Inc. The distribution date is expected to occur in early 2022.

January 27, 2022: Cryptyde currently a wholly owned subsidiary of Vinco Ventures, Inc (BBIG), which is expected to trade, if approved by Nasdaq, under the symbol TYDE, announced it has entered into definitive agreements for a debt and common equity raise of $42 million.

May 5, 2022: Vinco Ventures, Inc. (BBIG), announced that May 18, 2022 has been set as the record date for the dividend of shares of common stock of Cryptyde, Inc. to be distributed to Vinco stockholders in order to effect the separation of Vinco and Cryptyde into two independent, publicly traded companies.

The share dividend is expected to be distributed to Vinco stockholders on or about May 27, 2022. 

May 25, 2022: Vinco Ventures, Inc. (BBIG), announced that, due to contractual and regulatory conditions, the Company’s Board of Directors has decided to delay the distribution date for the previously announced spin-off of Cryptyde, Inc.

June 23, 2022: Vinco Ventures, Inc. (BBIG), announced that the Company’s Board of Directors has set June 29, 2022 as the distribution date for the dividend of shares of its common stock of Cryptyde, Inc. to be distributed, subject to certain conditions, to Vinco stockholders in order to effect the previously disclosed separation of Vinco and Cryptyde into two independent, publicly traded companies. 

On the Distribution Date, Vinco stockholders entitled to receive the Distribution will receive one share of Cryptyde common stock for every ten shares of Vinco common stock held.

Phoenix Motor Inc. 01/27/2021 SPI
SPI Energy Co., Ltd., spinoff details:

January 27, 2021: SPI Energy Co., Ltd., (SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors, today announced its Board of Directors approved the Company's plan to spin off Phoenix Motorcars, a wholly owned subsidiary of the Company's EdisonFuture subsidiary, through an initial public offering.

June 24, 2021: SPI Energy Co., Ltd. (SPI), a global renewable energy company and provider of solar storage and electric vehicle (EV) solutions for business, residential, government, logistics and utility customers and investors, announced the appointment of Janet Jie Chen as its new Chief Financial Officer.

June 7, 2022:

The Shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on June 8, 2022, under the ticker symbol “PEV.”

Phoenix Motor Inc. (PEV), announced the pricing of its initial public offering of 2,100,000 shares of common stock at a public offering price of $7.50 per Share, for total gross proceeds of $15,750,000

The Shares have been approved for listing on The Nasdaq Capital Market and are expected to commence trading on June 8, 2022, under the ticker symbol “PEV.”

 

EUROAPI 02/24/2020 SNY
Sanofi, spinoff details:

February 24, 2020: Sanofi (SNY) plans to create a major leading European company dedicated to the production and marketing to third parties of active pharmaceutical ingredients (API), which are the essential molecules responsible for the beneficial effects used in the composition of any drug. The project consists of creating a standalone company which would combine Sanofi’s API commercial and development activities with six of its European API production sites : Brindisi (Italy), Frankfurt Chemistry (Germany), Haverhill (UK), St Aubin les Elbeuf (France), Újpest (Hungary) and Vertolaye (France).

April 1, 2022: Investor Presentation

Update(s):

January 12, 2021: Sanofi chooses EUROAPI as the name for the future leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients (API).

April 1, 2022: EUROAPI first day of trading expected to occur on May 6, 2022 subject to the approval of the Distribution by the Ordinary and Extraordinary Shareholders’ Meeting to be held on May 3, 2022

May 6, 2022: EUROAPI (EAPI), a leading player in the API market, announces the success of its listing on the regulated market of Euronext Paris and its first day of trading

Bausch + Lomb Eye Health Business 08/06/2020 BHC
Bausch Health Companies Inc., spinoff details:

August 8, 2020: Bausch Health Companies (BHC) announced that it intends to spin off its leading eye health business into an independent publicly traded entity (“Bausch + Lomb - NewCo”) from the remainder of Bausch Health (“BHC”). The spinoff will establish two separate companies that include: •A fully integrated, pure play eye-health company built on the iconic Bausch + Lomb brand and long history of innovation; and •A diversified pharmaceutical company with leading positions in gastroenterology, aesthetics/dermatology, neurology and international pharmaceuticals.

Investor presentation

Update(s):

May 04, 2021: Bausch Health Companies Inc. (BHC) is preparing to spin off its eyecare business this fall while also considering suitable alternatives including a sale of the business, the company's CEO said. Spinoff details

August 03, 2021: Bausch Health (BHC) Announces Plans To Pursue An Initial Public Offering Of Solta Medical. Transaction Will Enable Bausch Health to Continue to Execute on its Previously Announced Spinoff of its Bausch + Lomb Eye Health Business.

November 02, 2021: Bausch Health Companies Inc. (BHC) announced that they expect to launch the proposed IPO of Solta Medical business in December 2021 or January 2022, and following that,  launch the Bausch + Lomb IPO approximately 30 days later.

January 13, 2022: Bausch Health Companies Inc. (BHC) announced that, in connection with its previously announced intention to separate its eye health business, its wholly owned subsidiary, Bausch + Lomb Corporation (BLCO), has publicly filed a Registration Statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC").

January 18, 2022: Bausch Health (BHC) announces it is seeking to refinance its existing Credit Agreement and Conditional Redemption Of Existing Notes- These steps will enable Bausch + Lomb IPO (BLCO) and facilitate full separation.

May 10, 2022: Bausch + Lomb Corporation (BLCO) and Bausch Health Companies Inc. (BHC) announced the closing of the initial public offering ("IPO") of Bausch + Lomb. A wholly owned subsidiary of Bausch Health sold 35,000,000 common shares at a public offering price of $18.00 per share for aggregate gross proceeds of $630 million, before deducting underwriting commissions and estimated offering expenses. 

The common shares began trading on the New York Stock Exchange and the Toronto Stock Exchange on May 6, 2022, in each case under the ticker symbol "BLCO." Bausch Health, together with its subsidiaries, now holds approximately 90.0% of the common shares of Bausch + Lomb (before giving effect to the over-allotment option).

Warner Bros. Discovery 05/17/2021 T
AT&T Inc., spinoff details:

May 17, 2021: AT&T Inc. (T) and Discovery, Inc. (DISCA, DISCB, DISCK) announced a definitive agreement to combine WarnerMedia’s premium entertainment, sports and news assets with Discovery’s leading nonfiction and international entertainment and sports businesses to create a premier, standalone global entertainment company.

Investor Presentation

Update(s):

June 1, 2021: Discovery, Inc. (DISCADISCBDISCK)  announced the new name of the proposed standalone global entertainment company that will emerge from the combination of WarnerMedia and Discovery assets: "Warner Bros. Discovery." 

June 23, 2021: EA Will Acquire Playdemic for $1.4 Billion in Cash.The remaining Warner Bros. Games portfolio is included in the recently announced WarnerMedia-Discovery transaction and will become part of the combined media and entertainment company after the expected close of that transaction. 

August 10, 2021: The company recently completed its DIRECTV transaction with TPG Capital and is moving forward with its plans to spin or split off WarnerMedia and combine it with Discovery to form a new entertainment company, Warner Bros. Discovery.

September 14, 2021: AT&T (T) continues to anticipate that its pending WarnerMedia-Discovery transaction will close by mid-2022

November 17, 2021: With regard to its pending WarnerMedia transaction with Discovery, the company continues to expect the transaction to close by mid-2022.

While dividend decisions are made at the discretion of the AT&T board of directors, Desroches said that after the transaction closes, AT&T expects an annual dividend payout ratio of 40% to 43% on anticipated free cash flows of $20 billion plus, equating to $8 billion to $9 billion in dividends annually.

December 6, 2021: Regarding the pending WarnerMedia-Discovery transaction, Stankey said the regulatory review process is proceeding as expected. Stankey reiterated expectations of leverage levels of 2.6x at the close of the deal and 2.5x by yearend 2023. 

February 1, 2022: AT&T Inc (T) said it will spin off WarnerMedia in a $43 billion transaction to merge its media properties with Discovery Inc (DISCA) and also cut its dividend by nearly half.

AT&T shareholders will own 71% of the new Warner Bros. Discovery company and will receive a 0.24 shares of Warner Bros. Discovery for each AT&T share they own. AT&T will have 7.2 billion diluted shares outstanding after the transaction closes.

February 1, 2022: The transaction, which will spin off 100% of AT&T’s interest in WarnerMedia to AT&T’s existing shareholders in a pro rata distribution, followed by the merger of WarnerMedia with Discovery, is expected to close in the second quarter of 2022.

On the closing date of the transaction, each AT&T shareholder will receive, on a tax-free basis, an estimated 0.24 shares of the new WBD common stock for each share of AT&T common stock held as of the record date for the pro rata distribution.

March 11, 2022: Discovery Inc (DISCAshareholders voted to approve the media company's $43 billion merger with WarnerMedia, moving the deal one step closer to completion.

March 25, 2022:

 AT&T Inc.* (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022. 
 
 On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

 AT&T Inc. (T) announced that it has declared a stock dividend to effect the spin-off of 100% of AT&T’s interest in WarnerMedia to AT&T’s shareholders. The record date for the stock dividend is the close of business on April 5, 2022.   On the closing date of the transaction, anticipated to be in April, AT&T shareholders will receive, on a tax-free basis, an estimated 0.24 shares of stock in Warner Bros. Discovery, Inc. (WBD) for each share of AT&T common stock.

April 8, 2022: Discovery, Inc. and AT&T Inc.* (Tannounced that they have closed their transaction to combine the WarnerMedia business with Discovery. The combination creates a premier standalone global media and entertainment company, Warner Bros. Discovery, Inc., which will begin trading on the Nasdaq with the start of trading on April 11, under the new ticker symbol “WBD.”

ESAB Corporation 03/04/2021 ENOV
Enovis Corporation (Previously Colfax Corporation), spinoff details:

March 4, 2021: Colfax Corporation (CFX), a leading diversified technology company, today announced its intention to separate its fabrication technology and specialty medical technology businesses into two differentiated, independent, and publicly-traded companies. The separation is intended to be structured in a tax-free manner and is targeted to be completed in the first quarter of 2022.

Investor Presentation

Update(s):

November 04, 2021: The Company is making meaningful progress on its expected tax-free spin-off of its ESAB business to Colfax shareholders in the form of a dividend in the first quarter of 2022. Colfax Corporation (CFX) announced that it will transition to its new name, Enovis, at the time of the separation.

February 22, 2022: Colfax (CFXintends to distribute 90% of the outstanding shares in ESAB to Colfax shareholders on a pro rata basis in a distribution intended to be tax-free to Colfax. The Company plans to divest its 10% retained shares in ESAB within 12 months after the spin-off in a tax-efficient exchange for its outstanding debt.

March 11, 2022: Colfax Corporation (CFX), announced the future composition of the Board of Directors of the Company, which will be renamed Enovis Corporation upon the consummation of the Company’s previously announced spin-off of its existing fabrication technology business, which will operate as ESAB Corporation.

March 14, 2022: Colfax (CFX) Announces Expected Completion Date of April 4, 2022 for Spin-Off of ESAB Corporation

Upon completion of the distribution, Colfax will effect the Reverse Stock Split and change its name to Enovis Corporation (“Enovis”). Following the distribution, Enovis will trade on the NYSE under the symbol “ENOV.”

March 28, 2022: Colfax (CFX) Announces Board of Directors for Post-Spinoff ESAB. Following the Separation, Mitchell P. Rales will serve as chairman of the Board, and current Colfax directors Patrick W. Allender, Rhonda L. Jordan, Didier Teirlinck and Rajiv Vinnakota will serve as directors of ESAB. 

April 5, 2022:

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced  the completion of its previously announced separationof its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 
Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

Enovis Corporation (ENOV), formerly known as Colfax Corporation, announced the completion of its previously announced separation of its fabrication technology business into an independent, publicly traded company, ESAB Corporation (ESAB). 

Immediately following the Separation, Enovis effected its previously announced reverse stock split of all issued and outstanding shares of Enovis common stock at a one-for-three ratio.

Premium member can access all Completed Spinoffs. Subscribe today.